<DOC>
	<DOCNO>NCT00572793</DOCNO>
	<brief_summary>The purpose study evaluate whether possible detect change concentration PP13 blood pregnant woman may go develop complication preeclampsia later pregnancy , change detect early enough allow early diagnosis treatment prevention complication reduce damage . This study test PP13 biomarker first trim pregnancy ability provide assessment risk development preeclampsia necessitates delivery 37 week gestation predict preeclampsia 34 week gestation .</brief_summary>
	<brief_title>A Study Evaluate Use Placenta Protein 13 ( PP13 ) First Trimester Pregnancy Diagnostic Aiding Tool Assessment Risk Developing Preeclampsia Women With Low Unknown Risk</brief_title>
	<detailed_description>After obtain informed consent maternal demographic , vital sign , height , weight , medical history , pregnancy dating , dipstick urine protein , previous lab result , nuchal translucency result uterine artery Doppler result ( do ) obtain . Blood PP13 obtain 7-13 week optionally 21-23 week . Hospitalization delivery information obtain via chart review evidence preeclampsia .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<criteria>Healthy , pregnant female Singleton fetus 7 0/7 13 6/7 week gestation Multifetal pregnancy Mental retardation Known fetal anomaly demise BMI &gt; 35 , serious medical condition</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>